Global Encephalitis Vaccine Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Encephalitis Vaccine Market Overview

1.1 Encephalitis Vaccine Definition

1.2 Global Encephalitis Vaccine Market Size Status and Outlook (2019-2032)

1.3 Global Encephalitis Vaccine Market Size Comparison by Region (2019-2032)

1.4 Global Encephalitis Vaccine Market Size Comparison by Type (2019-2032)

1.5 Global Encephalitis Vaccine Market Size Comparison by Application (2019-2032)

1.6 Global Encephalitis Vaccine Market Size Comparison by Sales Channel (2019-2032)

1.7 Encephalitis Vaccine Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Encephalitis Vaccine Market Snapshot

2.2 Global Encephalitis Vaccine Market Volume & Revenue (2019-2025)

2.3 Global Encephalitis Vaccine Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Encephalitis Vaccine Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Encephalitis Vaccine Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Encephalitis Vaccine Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Encephalitis Vaccine Market Segment Analysis by Player

3.1 Global Encephalitis Vaccine Sales and Market Share by Player (2023-2025)

3.2 Global Encephalitis Vaccine Revenue and Market Share by Player (2023-2025)

3.3 Global Encephalitis Vaccine Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Encephalitis Vaccine Market Segment Analysis by Type

4.1 Global Encephalitis Vaccine Market by Type

4.1.1 Inactivated Vaccine

4.1.2 Live Attenuated Vaccine

4.2 Global Encephalitis Vaccine Sales and Market Share by Type (2019-2025)

4.3 Global Encephalitis Vaccine Revenue and Market Share by Type (2019-2025)

4.4 Global Encephalitis Vaccine Average Price by Type (2019-2025)

4.5 Leading Players of Encephalitis Vaccine by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Encephalitis Vaccine Market Segment Analysis by Application

5.1 Global Encephalitis Vaccine Market by Application

5.1.1 Child

5.1.2 Adult

5.2 Global Encephalitis Vaccine Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Encephalitis Vaccine by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Encephalitis Vaccine Market Segment Analysis by Sales Channel

6.1 Global Encephalitis Vaccine Market by Sales Channel

6.1.1 Global Encephalitis Vaccine Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Encephalitis Vaccine Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Encephalitis Vaccine Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Encephalitis Vaccine by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Encephalitis Vaccine Market Segment Analysis by Region

7.1 Global Encephalitis Vaccine Market Size and CAGR by Region (2019-2032)

7.2 Global Encephalitis Vaccine Sales and Market Share by Region (2019-2025)

7.3 Global Encephalitis Vaccine Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Encephalitis Vaccine Market Share by Type

7.4.3 North America Encephalitis Vaccine Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Encephalitis Vaccine Market Share by Type

7.5.3 Europe Encephalitis Vaccine Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Encephalitis Vaccine Market Share by Type

7.6.3 Asia-Pacific Encephalitis Vaccine Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Encephalitis Vaccine Market Share by Type

7.7.3 South America Encephalitis Vaccine Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Encephalitis Vaccine Market Share by Type

7.8.3 Middle East & Africa Encephalitis Vaccine Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Encephalitis Vaccine Players

8.1 Valneva

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Sanofi Pasteur

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Biken

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Wuhan Institute of Biological Products

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Lanzhou Institute of Biological Products

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Chengdu Institute of Biological Products

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Tiantan Biological Products

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Liaoning Chengda

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Zhejiang Tianyuan Bio-Pharmaceutical

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Yisheng Bio

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Changchun Institute of Biological Products

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Encephalitis Vaccine

9.1 Industrial Chain of Encephalitis Vaccine

9.2 Upstream of Encephalitis Vaccine

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Encephalitis Vaccine

9.3.1 Leading Distributors/Dealers of Encephalitis Vaccine

9.3.2 Leading Consumers of Encephalitis Vaccine

Chapter 10. Global Encephalitis Vaccine Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Encephalitis Vaccine Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Encephalitis Vaccine Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Encephalitis Vaccine (2026-2032)

11.1 Global Encephalitis Vaccine Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Encephalitis Vaccine Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Encephalitis Vaccine Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Encephalitis Vaccine Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Encephalitis Vaccine Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Encephalitis Vaccine Import-Export (2019-2025)

12.2 Europe Encephalitis Vaccine Import-Export (2019-2025)

12.3 Asia Pacific Encephalitis Vaccine Import-Export (2019-2025)

12.4 South America Encephalitis Vaccine Import-Export (2019-2025)

12.5 Middle East & Africa Encephalitis Vaccine Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Encephalitis Vaccine Demand-Supply (2019-2025)

13.2 Europe Encephalitis Vaccine Demand-Supply (2019-2025)

13.3 Asia Pacific Encephalitis Vaccine Demand-Supply (2019-2025)

13.4 South America Encephalitis Vaccine Demand-Supply (2019-2025)

13.5 Middle East & Africa Encephalitis Vaccine Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources